Behind the $2.5 Billion Collaboration Framework, AI Drug Development Begins to Fill In Its Hardest Stretch
Insilico and Bora are planning a large AI drug development alliance with a striking headline value, but details remain thin; what the news really shows is that AI drug discovery companies are moving the battleground from algorithms into manufacturing, quality, and clinical verifiability.